CHAOJU EYE CARE HOLDINGS LIMITED Financials Chaoju Eye Care Holdings Limited
Equities
2219
KYG2047K1094
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.81 HKD | +0.79% |
|
+4.10% | -13.80% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,684 | 2,644 | 2,710 | 2,356 | - | - |
| Enterprise Value (EV) 1 | 3,684 | 2,644 | 2,710 | 2,356 | 2,356 | 2,356 |
| P/E ratio | 20 x | 13.8 x | 12.2 x | 8.81 x | 7.17 x | 6.19 x |
| Yield | 1.63% | 4.07% | - | 4.58% | 5.15% | - |
| Capitalization / Revenue | 3.69 x | 2.67 x | 1.98 x | 1.45 x | 1.25 x | 1.04 x |
| EV / Revenue | 3.69 x | 2.67 x | 1.98 x | 1.45 x | 1.25 x | 1.04 x |
| EV / EBITDA | 13.7 x | 7.54 x | 7.14 x | 5.14 x | 4.1 x | 3.73 x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | 1.54 x | 1.16 x | - | 0.97 x | 0.89 x | 0.74 x |
| Nbr of stocks (in thousands) | 707,625 | 707,625 | 674,685 | 673,836 | - | - |
| Reference price 2 | 5.207 | 3.736 | 4.017 | 3.496 | 3.496 | 3.496 |
| Announcement Date | 3/28/22 | 3/28/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 997.8 | 990 | 1,370 | 1,628 | 1,891 | 2,265 |
| EBITDA 1 | - | 268.7 | 350.4 | 379.7 | 458.6 | 575.3 | 631.1 |
| EBIT 1 | - | 221.1 | 251 | 311.5 | 370 | 463.2 | 521 |
| Operating Margin | - | 22.16% | 25.36% | 22.74% | 22.73% | 24.5% | 23% |
| Earnings before Tax (EBT) 1 | 157.6 | 210.6 | 239.1 | 299.2 | 363.2 | 448 | 516.9 |
| Net income 1 | 124.1 | 161.7 | 187.8 | 228.9 | 276.5 | 343.3 | 396.8 |
| Net margin | - | 16.21% | 18.96% | 16.72% | 16.99% | 18.16% | 17.52% |
| EPS 2 | - | 0.2600 | 0.2700 | 0.3300 | 0.3967 | 0.4875 | 0.5650 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | 0.0849 | 0.1522 | - | 0.1600 | 0.1800 | - |
| Announcement Date | 6/24/21 | 3/28/22 | 3/28/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 11.4% | 7.39% | 9.88% | 11% | 13.1% | 12.1% |
| ROA (Net income/ Total Assets) | - | 9% | 6.19% | 8.11% | 9.03% | 11.3% | 10.2% |
| Assets 1 | - | 1,798 | 3,035 | 2,823 | 3,064 | 3,038 | 3,890 |
| Book Value Per Share 2 | - | 3.370 | 3.220 | - | 3.610 | 3.920 | 4.740 |
| Cash Flow per Share 2 | - | - | 0.3900 | - | 0.4900 | 0.6100 | - |
| Capex 1 | - | 60.2 | 125 | - | 222 | 259 | 167 |
| Capex / Sales | - | 6.03% | 12.64% | - | 13.63% | 13.72% | 7.37% |
| Announcement Date | 6/24/21 | 3/28/22 | 3/28/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.496
CNY
Average target price
5.922
CNY
Spread / Average Target
+69.37%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.80% | 322M | |
| -17.07% | 16.21B | |
| +3.60% | 12.44B | |
| +5.64% | 11.58B | |
| +4.63% | 10.79B | |
| +25.36% | 8.26B | |
| -0.80% | 7.68B | |
| +22.18% | 7.06B | |
| +5.77% | 6.67B | |
| +52.00% | 4.66B |
- Stock Market
- Equities
- 2219 Stock
- Financials Chaoju Eye Care Holdings Limited
